Literature DB >> 7747790

Lymphangiosarcoma in late-onset hereditary lymphedema: case report and nosological implications.

H C Andersson1, D M Parry, J J Mulvihill.   

Abstract

Hereditary lymphedemas that are not associated with other malformations usually affect the lower limbs and are inherited in an autosomal dominant fashion. These non-syndromic hereditary lymphedemas are categorized by their age of onset, being either congenital (Milroy disease) or having an onset in childhood or around puberty (Meige disease). We describe a family in which three individuals in three generations had unusually late onset of lymphedema in their mid-twenties or thirties. The proband additionally developed a very rare lymphangiosarcoma. This tumor, usually associated with post-mastectomy lymphedema, has not been described in late-onset hereditary lymphedema. Because of an unusually high incidence of multiple primary tumors in association with lymphangiosarcoma in the literature (approximately 10%) and the proband's own familial cancer background, we speculate that an inherited predisposition to malignancy may underlie the development of lymphedema-associated lymphangiosarcoma.

Entities:  

Mesh:

Year:  1995        PMID: 7747790     DOI: 10.1002/ajmg.1320560116

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  3 in total

1.  Cutaneous epithelioid clear cells angiosarcoma in a young woman with congenital lymphedema.

Authors:  Flore Tabareau-Delalande; Anne de Muret; Elodie Miquelestorena-Standley; Anne-Valérie Decouvelaere; Gonzague de Pinieux
Journal:  Case Rep Pathol       Date:  2013-09-03

2.  Four generations of rare familial lymphedema (Milroy disease).

Authors:  Sankalp Gokhale; Sanjay Gokhale
Journal:  Med Princ Pract       Date:  2013-06-04       Impact factor: 1.927

Review 3.  The Impact of Estrogen Receptor in Arterial and Lymphatic Vascular Diseases.

Authors:  Coralie Fontaine; Florent Morfoisse; Florence Tatin; Audrey Zamora; Rana Zahreddine; Daniel Henrion; Jean-François Arnal; Françoise Lenfant; Barbara Garmy-Susini
Journal:  Int J Mol Sci       Date:  2020-05-04       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.